| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Allosteric kidney-type glutaminase (GLS) inhibitors with a mercaptoethyl linker
|
Duvall, Bridget
|
|
|
28 |
20 |
p.
|
article
|
| 2 |
A new naphthalene derivative with anti-amyloidogenic activity as potential therapeutic agent for Alzheimer's disease
|
Rivera-Marrero, Suchitil
|
|
|
28 |
20 |
p.
|
article
|
| 3 |
An orthogonal seryl-tRNA synthetase/tRNA pair for noncanonical amino acid mutagenesis in Escherichia coli
|
Zambaldo, Claudio
|
|
|
28 |
20 |
p.
|
article
|
| 4 |
Design, synthesis and evaluation of a baicalin and berberine hybrid compound as therapeutic agent for ulcerative colitis
|
Jia, Dan
|
|
|
28 |
20 |
p.
|
article
|
| 5 |
Dihydrobenzoxazinone derivatives as aldose reductase inhibitors with antioxidant activity
|
Chen, Huan
|
|
|
28 |
20 |
p.
|
article
|
| 6 |
Editorial Board
|
|
|
|
28 |
20 |
p.
|
article
|
| 7 |
Exploring the physicochemical and antiproliferative properties of biaryl-linked [13]-macrodilactones
|
Chen, Chengsheng
|
|
|
28 |
20 |
p.
|
article
|
| 8 |
Fragment-based modification of 2,4-diarylaminopyrimidine derivatives as ALK and ROS1 dual inhibitors to overcome secondary mutants
|
Zhu, Minglin
|
|
|
28 |
20 |
p.
|
article
|
| 9 |
Graphical Abstract Contents Continued
|
|
|
|
28 |
20 |
p.
|
article
|
| 10 |
Graphical abstract TOC
|
|
|
|
28 |
20 |
p.
|
article
|
| 11 |
Graphical abstract TOC
|
|
|
|
28 |
20 |
p.
|
article
|
| 12 |
Protection of all cleavable sites of DNA with the multiple CGCG or continuous CGG sites from the restriction enzyme, indicative of simultaneous binding of small ligands
|
Murase, Hirotaka
|
|
|
28 |
20 |
p.
|
article
|
| 13 |
Pyrroformyl-containing 2,4-diaminopyrimidine derivatives as a new optimization strategy of ALK inhibitors combating mutations
|
Cao, Meng
|
|
|
28 |
20 |
p.
|
article
|
| 14 |
Rational design of cell-permeable cyclic peptides containing a d-Pro-l-Pro motif
|
Wen, Jin
|
|
|
28 |
20 |
p.
|
article
|
| 15 |
Recent advances in the design of RAR α and RAR β agonists as orally bioavailable drugs. A review
|
Borthwick, Alan D.
|
|
|
28 |
20 |
p.
|
article
|
| 16 |
RNA drug discovery: Conformational restriction enhances specific modulation of the T-box riboswitch function
|
Armstrong, Ian
|
|
|
28 |
20 |
p.
|
article
|
| 17 |
Small-molecule active pharmaceutical ingredients of approved cancer therapeutics inhibit human aspartate/asparagine-β-hydroxylase
|
Brewitz, Lennart
|
|
|
28 |
20 |
p.
|
article
|
| 18 |
Synthesis, biological evaluation and in silico modeling of novel pan-genotypic NS5A inhibitors
|
Ivashchenko, Andrey A.
|
|
|
28 |
20 |
p.
|
article
|
| 19 |
The splicing modulator sulfonamide indisulam reduces AR-V7 in prostate cancer cells
|
Melnyk, James E.
|
|
|
28 |
20 |
p.
|
article
|
| 20 |
Widening the bottleneck: Heterologous expression, purification, and characterization of the Ktedonobacter racemifer minimal type II polyketide synthase in Escherichia coli
|
Klein, Joshua G.
|
|
|
28 |
20 |
p.
|
article
|
Journal description